# Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer

> **NCT00898911** · — · COMPLETED · sponsor: **ECOG-ACRIN Cancer Research Group** · enrollment: 30 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **OTHER:** matrix-assisted laser desorption/ionization time of flight mass spectrometry

## Key facts

- **NCT ID:** NCT00898911
- **Lead sponsor:** ECOG-ACRIN Cancer Research Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07-08
- **Primary completion:** 2012-04-08
- **Final completion:** 2012-04-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00898911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00898911, "Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00898911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*